Peptides designed by artificial intelligence restrict both drug-resistant bacteria and rapidly evolving viruses.

Copenhagen, Denmark Monday, March 10, 2025, 11:00 Hrs [IST] ...

The UK MHRA has validated Bavarian Nordics’ marketing authorisation application for its single-dose chikungunya vaccine.

Bavarian Nordic A/S (OMX: BAVA) announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has ...

The following is a summary of “Transcriptomic insights into early mechanisms underlying post-chikungunya chronic inflammatory ...

Experts at BJMC and SGH are sequencing Chikungunya virus to investigate mutations linked to severe cases and outbreaks in ...

(WDTN) - Five people who recently received a vaccine that prevents a disease caused by chikungunya virus have been ...

Hyderabad: Biological E. Limited has announced a strategic partnership with Bavarian Nordic A/S to expand access to Bavarian ...

▎药明康德内容团队编辑BavarianNordic今日宣布，欧盟委员会已批准Vimkunya（基孔肯雅热重组疫苗），用于建立主动免疫，以预防12岁及以上人群感染基孔肯雅热病毒（CHIKV）所致的疾病。根据新闻稿，该疫苗是首个在欧洲获批适用于12岁及以 ...

COPENHAGEN, Denmark, February 28, 2025 - Bavarian Nordic A/S (OMX: BAVA) today announced that the European Commission has granted marketing authorization in Europe for VIMKUNYA ® for active ...

First chikungunya vaccine approved in Europe for persons as young as 12 years old. <li /> On track for launch in key European markets i ...

About chikungunya Chikungunya is a mosquito-borne disease caused by the chikungunya virus (CHIKV). In the past 20 years, the virus has emerged across several regions in Asia, Africa, and the ...